Ferroptosis: A Novel Therapeutic Target for Ischemia-Reperfusion Injury

89Citations
Citations of this article
45Readers
Mendeley users who have this article in their library.

Abstract

Ischemia-reperfusion (I/R) injury is a major cause of cell death and organ damage in numerous pathologies, including myocardial infarction, stroke, and acute kidney injury. Current treatment methods for I/R injury are limited. Ferroptosis, which is a newly uncovered type of regulated cell death characterized by iron overload and lipid peroxidation accumulation, has been investigated in various diseases. There is increasing evidence of a close association between ferroptosis and I/R injury, with ferroptosis frequently identified as a new therapeutic target for the management of I/R injury. This review summarizes the current status of ferroptosis and discusses its relationship with I/R injury, as well as potential treatment strategies targeting it.

Cite

CITATION STYLE

APA

Chen, Y., Fan, H., Wang, S., Tang, G., Zhai, C., & Shen, L. (2021, August 10). Ferroptosis: A Novel Therapeutic Target for Ischemia-Reperfusion Injury. Frontiers in Cell and Developmental Biology. Frontiers Media S.A. https://doi.org/10.3389/fcell.2021.688605

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free